Personalis ROA 2018-2024 | PSNL
Current and historical return on assets (ROA) values for Personalis (PSNL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Personalis ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-09-30 |
$-0.09B |
$0.24B |
-43.50% |
| 2024-06-30 |
$-0.08B |
$0.19B |
-39.38% |
| 2024-03-31 |
$-0.09B |
$0.20B |
-41.52% |
| 2023-12-31 |
$-0.11B |
$0.23B |
-44.81% |
| 2023-09-30 |
$-0.11B |
$0.23B |
-43.42% |
| 2023-06-30 |
$-0.11B |
$0.25B |
-38.87% |
| 2023-03-31 |
$-0.11B |
$0.27B |
-36.74% |
| 2022-12-31 |
$-0.11B |
$0.29B |
-33.48% |
| 2022-09-30 |
$-0.10B |
$0.32B |
-28.06% |
| 2022-06-30 |
$-0.09B |
$0.36B |
-24.37% |
| 2022-03-31 |
$-0.08B |
$0.38B |
-20.66% |
| 2021-12-31 |
$-0.07B |
$0.40B |
-16.42% |
| 2021-09-30 |
$-0.06B |
$0.41B |
-16.21% |
| 2021-06-30 |
$-0.05B |
$0.38B |
-15.71% |
| 2021-03-31 |
$-0.04B |
$0.40B |
-16.99% |
| 2020-12-31 |
$-0.04B |
$0.25B |
-20.71% |
| 2020-09-30 |
$-0.04B |
$0.25B |
-19.89% |
| 2020-06-30 |
$-0.03B |
$0.15B |
-20.81% |
| 2020-03-31 |
$-0.03B |
$0.15B |
-17.55% |
| 2019-12-31 |
$-0.03B |
$0.16B |
-20.43% |
| 2019-06-30 |
$-0.02B |
$0.19B |
-33.33% |
| 2019-03-31 |
$-0.02B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.261B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
